Joshua L. Deffenbaugh , Kyeong-Joo Jung , Shawn P. Murphy , Yue Liu , Christina N. Rau , Cora L. Petersen-Cherubini , Patrick L. Collins , Dongjun Chung , Amy E. Lovett-Racke
{"title":"Novel model of multiple sclerosis induced by EBV-like virus generates a unique B cell population","authors":"Joshua L. Deffenbaugh , Kyeong-Joo Jung , Shawn P. Murphy , Yue Liu , Christina N. Rau , Cora L. Petersen-Cherubini , Patrick L. Collins , Dongjun Chung , Amy E. Lovett-Racke","doi":"10.1016/j.jneuroim.2024.578408","DOIUrl":null,"url":null,"abstract":"<div><p>Epstein-Barr virus (EBV) is deemed a necessary, yet insufficient factor in the development of multiple sclerosis (MS). In this study, myelin basic protein-specific transgenic T cell receptor mice were infected with murid gammaherpesvirus 68 virus (MHV68), an EBV-like virus that infects mice, resulting in the onset neurological deficits at a significantly higher frequency than influenza or mock-infected mice. MHV68 infected mice exhibited signs including optic neuritis and ataxia which are frequently observed in MS patients but not in experimental autoimmune encephalomyelitis mice. MHV68-infected mice exhibited increased focal immune cell infiltration in the central nervous system. Single cell RNA sequencing identified the emergence of a population of B cells that express genes associated with antigen presentation and costimulation, indicating that gammaherpesvirus infection drives a distinct, pro-inflammatory transcriptional program in B cells that may promote autoreactive T cell responses in MS.</p></div>","PeriodicalId":16671,"journal":{"name":"Journal of neuroimmunology","volume":"394 ","pages":"Article 578408"},"PeriodicalIF":2.9000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165572824001279/pdfft?md5=af5b53f47d01b4f9e6299cf1ecdc7ed0&pid=1-s2.0-S0165572824001279-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroimmunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165572824001279","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Epstein-Barr virus (EBV) is deemed a necessary, yet insufficient factor in the development of multiple sclerosis (MS). In this study, myelin basic protein-specific transgenic T cell receptor mice were infected with murid gammaherpesvirus 68 virus (MHV68), an EBV-like virus that infects mice, resulting in the onset neurological deficits at a significantly higher frequency than influenza or mock-infected mice. MHV68 infected mice exhibited signs including optic neuritis and ataxia which are frequently observed in MS patients but not in experimental autoimmune encephalomyelitis mice. MHV68-infected mice exhibited increased focal immune cell infiltration in the central nervous system. Single cell RNA sequencing identified the emergence of a population of B cells that express genes associated with antigen presentation and costimulation, indicating that gammaherpesvirus infection drives a distinct, pro-inflammatory transcriptional program in B cells that may promote autoreactive T cell responses in MS.
爱泼斯坦-巴氏病毒(EBV)被认为是多发性硬化症(MS)发病的一个必要但不充分的因素。在这项研究中,髓鞘碱性蛋白特异性转基因 T 细胞受体小鼠感染了鼠γ疱疹病毒 68 病毒(MHV68),这是一种能感染小鼠的 EBV 类病毒,导致小鼠出现神经功能缺损的频率明显高于流感或模拟感染小鼠。感染 MHV68 的小鼠表现出包括视神经炎和共济失调在内的症状,这些症状在多发性硬化症患者中经常出现,但在实验性自身免疫性脑脊髓炎小鼠中却没有。MHV68感染的小鼠表现出中枢神经系统局灶性免疫细胞浸润增加。单细胞 RNA 测序确定了 B 细胞群的出现,它们表达与抗原递呈和成本刺激相关的基因,这表明γ疱疹病毒感染在 B 细胞中驱动了一种独特的促炎症转录程序,该程序可能会促进多发性硬化症患者的自反应性 T 细胞反应。
期刊介绍:
The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.